Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Promidian was a boutique management consulting firm focused on the pharmaceutical, biotechnology, and broader life sciences industries. The firm provided commercial and strategic advisory services including market assessment, analytics, pricing and market access, launch strategy, brand strategy, medical affairs support, and corporate strategy. Promidian did not appear to develop therapeutic products of its own; instead, it advised biopharma clients across the product lifecycle from development through launch and in-market commercialization. By 2019 it was operating as "Promidian, an EVERSANA company," and its capabilities were later folded into EVERSANA's consulting organization. As a result, Promidian is best understood as a former life sciences consulting brand rather than an independent drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Promidian.